Disclosed are pyridodihydropyrazinone compounds, processes for preparing them and their use as pharmaceutical compositions. The compounds according to the invention correspond to general formula (I),while the groups L, R1, R2, R3, R4 and R5 may have the meanings given in the claims and specification.